Dimethylformamide → HCID 71015337, compound
Reaction equation
[O:1]([C:8]1[CH:13]=[CH:12][C:11]([C:14]2[C:22]3[C:17](=[N:18][CH:19]=[N:20][C:21]=3[NH2:23])[N:16]([CH2:24][C@H:25]3[CH2:29][CH2:28][CH2:27][NH:26]3)[N:15]=2)=[CH:10][CH:9]=1)[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.C(N(CC)CC)C.N1(OC(N(C)C)=[N+](C)C)[C:41]2N=[CH:43][CH:44]=[CH:45][C:40]=2N=N1.[F:54][P-](F)(F)(F)(F)F.CN([CH:64]=[O:65])C>>[NH2:23][C:21]1[N:20]=[CH:19][N:18]=[C:17]2[N:16]([CH2:24][C@H:25]3[CH2:29][CH2:28][CH2:27][N:26]3[C:64](=[O:65])[C:41]([F:54])=[CH:40][CH:45]3[CH2:43][CH2:44]3)[N:15]=[C:14]([C:11]3[CH:10]=[CH:9][C:8]([O:1][C:2]4[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=4)=[CH:13][CH:12]=3)[C:22]=12Participants
Procedure
A mixture of (E/Z)-3-cyclopropyl-2-fluoroacrylic acid (68 mg, 0.52 mmol), (R)-3-(4-phenoxyphenyl)-1-(pyrrolidin-2-ylmethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine (158 mg, 0.52 mmol), triethylamine (69 mg, 0.68 mmol) and DMF (4 mL) were stirred at room temperature for 10 mins. O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium PF6 (257 mg, 0.68 mmol) was then added and the mixture was stirred for 75 min. The solvent was evaporated and the oil was worked up with ethylacetate and water. Organic layer was washed with brine and dried with MgSO4. Purification with column chromatography (SiO2, MeOH|DCM with gradient form 1% to 2% in total 500 mL) gave (R)-1-(2-((4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)methyl)pyrrolidin-1-yl)-3-cyclopropyl-2-fluoroprop-2-en-1-one. MS (pos. ion) m/z: 499 (M+1).
Workup
- stirringthe mixture was stirred for 75 min
- customThe solvent was evaporated
- washOrganic layer was washed with brine
- dry with materialdried with MgSO4
- customPurification with column chromatography (SiO2, MeOH|DCM with gradient form 1% to 2% in total 500 mL)
Sources & evidence
- ORD record
- ord-6c9c8270eb684981b9e17baf06904fda
- Source dataset
- uspto-grants-2016_06
- Patent number
- US09376438B2
Reaction notes
Loading…